TY - JOUR
T1 - Clinical applications of cardiac computed tomography
T2 - a consensus paper of the European Association of Cardiovascular Imaging - part II
AU - Pontone, Gianluca
AU - Rossi, Alexia
AU - Guglielmo, Marco
AU - Dweck, Marc R.
AU - Gaemperli, Oliver
AU - Nieman, Koen
AU - Pugliese, Francesca
AU - Maurovich-Horvat, Pal
AU - Gimelli, Alessia
AU - Cosyns, Bernard
AU - Achenbach, Stephan
N1 - Publisher Copyright:
© 2022 Published on behalf of the European Society of Cardiology.
PY - 2022/4/1
Y1 - 2022/4/1
N2 - Cardiac computed tomography (CT) was initially developed as a non-invasive diagnostic tool to detect and quantify coronary stenosis. Thanks to the rapid technological development, cardiac CT has become a comprehensive imaging modality which offers anatomical and functional information to guide patient management. This is the second of two complementary documents endorsed by the European Association of Cardiovascular Imaging aiming to give updated indications on the appropriate use of cardiac CT in different clinical scenarios. In this article, emerging CT technologies and biomarkers, such as CT-derived fractional flow reserve, perfusion imaging, and pericoronary adipose tissue attenuation, are described. In addition, the role of cardiac CT in the evaluation of atherosclerotic plaque, cardiomyopathies, structural heart disease, and congenital heart disease is revised.
AB - Cardiac computed tomography (CT) was initially developed as a non-invasive diagnostic tool to detect and quantify coronary stenosis. Thanks to the rapid technological development, cardiac CT has become a comprehensive imaging modality which offers anatomical and functional information to guide patient management. This is the second of two complementary documents endorsed by the European Association of Cardiovascular Imaging aiming to give updated indications on the appropriate use of cardiac CT in different clinical scenarios. In this article, emerging CT technologies and biomarkers, such as CT-derived fractional flow reserve, perfusion imaging, and pericoronary adipose tissue attenuation, are described. In addition, the role of cardiac CT in the evaluation of atherosclerotic plaque, cardiomyopathies, structural heart disease, and congenital heart disease is revised.
KW - artificial intelligence
KW - cardiac computed tomography
KW - cardiomyopathy
KW - coronary computed tomography angiography (CCTA)
KW - CT perfusion imaging
KW - FFR
KW - fractional flow reserve
KW - myocardial ischaemia
KW - plaque imaging
KW - radiomics
KW - structural heart disease
UR - http://www.scopus.com/inward/record.url?scp=85127850353&partnerID=8YFLogxK
U2 - 10.1093/ehjci/jeab292
DO - 10.1093/ehjci/jeab292
M3 - Article
C2 - 35175348
AN - SCOPUS:85127850353
SN - 2047-2404
VL - 23
SP - E136-E161
JO - European Heart Journal Cardiovascular Imaging
JF - European Heart Journal Cardiovascular Imaging
IS - 4
ER -